AMCP Summary – Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency

On Nov 1, The Centers for Medicare and Medicaid Services (CMS) issued a proposed rule that updates Medicare Advantage (MA or Part C) and the Medicare Prescription Drug Benefit Program (Part D). The purpose of the proposed rule is to implement several provisions in the Bipartisan Budget Act of 2018, improve program quality and accessibility, and propose policies that strengthen program integrity. Proposed provisions are intended to reduce provider burden and promote flexibility and innovation that will provide MA and Part D sponsors with tools to improve quality of care and increase choice for MA and Part D enrollees. CMS estimates that, if finalized, the proposed changes would result in $4.5 billion dollars in savings to the Medicare Trust Funds over ten years.

View More

Related